International Pharmaceutical Regulatory Monitor

April 2012 | Vol. 40 No. 4

Singapore, Malaysia Agree to Joint Inspections, Information Exchange

Singapore’s Health Sciences Authority (HSA) and Malaysia’s National Pharmaceutical Control Board (NPCB) will exchange drug registration assessment reports and conduct joint inspections of manufacturing plants, under a March 27 memorandum of understanding.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

FDA Investigates Global Recall System as Part of International Pivot FDA, EMA Ramp Up Interactions, Search for New QbD Pilot Applicants Obama’s Call for Global Regulatory Harmonization Could Help Industry Obama’s Call for International Regulatory Harmonization Could Help Drug Industry

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.